Stephan Madersbacher

Abteilung fur Urologie & Andrologie, Wien Krankenanstaltenverbund, Austria

Stephan Madersbacher

Academic positions:

All industry positions (in last five years):

Research interests:

Any other information:

Any competing interests declared are displayed with individual evaluations.

: Urology > Benign Prostatic Hyperplasia & Prostatitis (15 November 2005 - 12 November 2007)

All recent recommendations

• 6.0
  Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study.
  Recommended by Stephan Madersbacher
  
• 6.4
  Saw palmetto for benign prostatic hyperplasia.
  Recommended by Peter Gilling, Stephan Madersbacher